119
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017

ORCID Icon, , , , & ORCID Icon
Pages 1165-1175 | Published online: 21 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kuang-Ming Liao, Yi-Ju Chen, Chuan-Wei Shen, Shao-Kai Ou & Chung-Yu Chen. (2022) The Influence of Influenza Virus Infections in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2253-2261.
Read now
Yan Yin, Jinfu Xu, Shaoxi Cai, Yahong Chen, Yan Chen, Manxiang Li, Zhiqiang Zhang & Jian Kang. (2022) Development and Validation of a Multivariable Prediction Model to Identify Acute Exacerbation of COPD and Its Severity for COPD Management in China (DETECT Study): A Multicenter, Observational, Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2093-2106.
Read now
Anders Løkke, Peter Lange, Jesper Lykkegaard, Rikke Ibsen, Maria Andersson, Sofie de Fine Licht & Ole Hilberg. (2021) Economic Burden of COPD by Disease Severity – A Nationwide Cohort Study in Denmark. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 603-613.
Read now

Articles from other publishers (5)

Julie Shi, Lirong Liang & Manqi Hou. (2023) The impacts of China's drug price zero-markup policy on medical expenditures and health outcomes. China Economic Review 79, pages 101949.
Crossref
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian & Chen Wang. (2023) Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL). Therapeutic Advances in Respiratory Disease 17, pages 175346662311673.
Crossref
Jiachen Li, Lirong Liang, Siyu Cao, Hengmo Rong, Lin Feng, Di Zhang, Shuilian Chu, Hang Jing & Zhaohui Tong. (2022) Secular trend and risk factors of 30-day COPD-related readmission in Beijing, China. Scientific Reports 12:1.
Crossref
Yong-Li Gu, Zeng-Xian Sun, Ying Sun, Yan Wen, Xin Guan, Dao-Li Jiang, Cong Cheng & Huan Gu. (2022) A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease. Frontiers in Pharmacology 13.
Crossref
Ariuntuya Tuvdendorj, Otgonjargal Dechinkhorloo, Bayarsaikhan Dorjsuren, Erik Buskens & Talitha Feenstra. (2021) The costs of inappropriate referral pathways in inpatient care for three major noncommunicable diseases in Mongolia: a national registry-based analysis. BMC Health Services Research 21:1.
Crossref